The prognostic significance of Jun transcription factors in ovarian cancer

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 10, 2013, Pages 1673-1680

  Eckhoff, Kerstin ^a   Flurschütz, Roland ^a   Trillsch, Fabian ^a   Mahner, Sven ^a   Jänicke, Fritz ^a   Milde Langosch, Karin ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

AP 1; c Jun; JunB; JunD; Ovarian cancer; Prognosis

Indexed keywords

PHOSPHOPROTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; GERMANY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PHOSPHOPROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84884671209     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1489-y     Document Type: Article

References (29)

1. Agarwal SK, Novotny EA, Crabtree JS et al (2003) Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter. Proc Natl Acad Sci USA 100:10770-10775
2. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072:129-157
3. Behrens A, Sibilia M, Wagner EF (1999) Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 21:326-329
4. Chinenov Y, Kerppola TK (2001) Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2:2438-2452
5. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239-252
6. Dérijard B, Hibi M, Wu I-H, Barrett T, Su B, Deng T, Karin M, Davis RJ (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037
7. Du Bois A, Quinn M, Thigpen T et al (2004) 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol 16(Suppl 8):viii7-viii12
8. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374-1403
9. Gerald D, Berra E, Frapart YM (2004) JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118:781-794
10. Hein S, Mahner S, Kanowski C, Löning T, Jänicke F, Milde-Langosch K (2009) Expression of Jun and Fos proteins in ovarian tumours of different malignant potential and in ovarian cancer cell lines. Oncol Rep 22:177-183
11. Jochum W, Passegue E, Wagner EF (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20:2401-2412
12. Johnson RS, van Lingen B, Papaioannou VE, Spiegelman BM (1993) A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev 7:1309-1317
13. Karin M (1995) The regulation of AP-1-activity by mitogen-activated protein kinases. J Biol Chem 270(28):16483-16486
14. Kimura R, Ishikawa C, Rokkaku T, Janknecht R, Mori N (2011) Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells. Biochim Biophys Acta 1813(8):1543-1553
15. Le-Niculescu H, Bonfoco E, Kasuya Y, Claret F-X, Green DR, Karin M (1999) Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol Cell Biol 19:751-763
16. Mahner S, Baasch C, Schwarz J, Hein S, Wölber L, Jänicke F, Milde-Langosch K (2008) C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. Br J Cancer 99:1269-1275
17. Mathas S, Hinz M, Anagnostopoulos I, Krappmann D, Lietz AQ, Jundt F, Bommert K, Mechta-Grigoriou F, Stein H, Dörken B, Scheidereit C (2002) Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J 21(15):4104-4113
18. Milde-Langosch K (2005) The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 41(16):2449-2461
19. Milde-Langosch K, Janke S, Wagner I, Schröder C, Streichert T, Bamberger A-M, Jänicke F, Löning T (2008) Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility. Breast Cancer Res Treat 107(3):337-347
20. Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S, Yaniv M (1994) Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76:747-760
21. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR (1991) Phosphorylation of c-jun mediated by MAP kinases. Nature 353(6345):670-674
22. Shaulian E (2010) AP-1 - the Jun proteins: oncogenes or tumor suppressor in disguise? Cell Signal 22:894-899
23. Toft DJ, Rosenberg SB, Bergers G, Volpert O, Linzer DIH (2001) Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression. Proc Natl Acad Sci USA 98:13055-13059
24. Vivas-Mejia P, Benito JM, Fernandez A et al (2010) c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer. Clin Cancer Res 16:184-194
25. Weiss C, Schneider S, Wagner EF, Zhang X, Seto E, Bohmann D (2003) JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. EMBO J 22:3686-3695
26. Weitzman JB, Fiette L, Matsuo K, Yaniv M (2000) JunD protects cells from p53-dependent senescence and apoptosis. Mol Cell 6:1109-1119
27. Wisdom R, Johnson RS, Moore C (1999) c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 18:188-197
28. Zhou H, Gao J, Lu ZY, Lu L, Dai B, Xu M (2007) Role of c-Fos/JunD in protecting stress-induced cell death. Cell Prolif 40:431-444
29. Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A (2000) High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Oncogene 19:4011-4021